speb/financial-data huggingface dataset:
BH.A income_statement (annual, 2025-12-31) — EBIT: -34049000.00
BH.A income_statement (quarterly, 2025-12-31) — EBIT: -57078000.00
BH.A income_statement (annual, 2025-12-31) — EBITDA: 6730000.00
BH.A income_statement (quarterly, 2025-12-31) — EBITDA: -46373000.00
BH.A income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -67001000.00
BH.A income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: -60016000.00
BH.A cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 67001000.00
BH.A cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 39000.00
BH.A cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -15000.00
BH.A cash_flow (annual, 2025-12-31) — End Cash Position: 269493000.00
BH.A cash_flow (quarterly, 2025-12-31) — End Cash Position: 269493000.00
BH.A cash_flow (annual, 2025-12-31) — Financing Cash Flow: 196533000.00
BH.A cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 7811000.00
BH.A cash_flow (annual, 2025-12-31) — Free Cash Flow: 76606000.00
BH.A cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 6368000.00
BH.A cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -528000.00
BH.A cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -4682000.00
BH.A income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 11877000.00
BH.A income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 1665000.00
BH.A income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 528000.00
BH.A income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -2303000.00
BH.A balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1350000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1350000.00
BH.A balance_sheet (annual, 2025-12-31) — Goodwill: 52568000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Goodwill: 52568000.00
BH.A balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 76242000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 76242000.00
BH.A balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 25629000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 25629000.00
BH.A balance_sheet (annual, 2025-12-31) — Gross PPE: 872242000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Gross PPE: 872242000.00
BH.A income_statement (annual, 2025-12-31) — Gross Profit: 149415000.00
BH.A income_statement (quarterly, 2025-12-31) — Gross Profit: 36476000.00
BH.A income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 1251000.00
BH.A income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
BH.A cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 2736000.00
BH.A income_statement (annual, 2025-12-31) — Interest Expense: 13642000.00
BH.A income_statement (quarterly, 2025-12-31) — Interest Expense: 6980000.00
BH.A income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 13642000.00
BH.A income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 6980000.00
BH.A cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 11646000.00
BH.A balance_sheet (annual, 2025-12-31) — Inventory: 3769000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Inventory: 3769000.00
BH.A balance_sheet (annual, 2025-12-31) — Invested Capital: 770419000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Invested Capital: 770419000.00
BH.A cash_flow (annual, 2025-12-31) — Investing Cash Flow: -65470000.00
BH.A cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -29270000.00
BH.A balance_sheet (annual, 2025-12-31) — Investments And Advances: 154275000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 154275000.00
BH.A balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 154275000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 154275000.00
BH.A cash_flow (annual, 2025-12-31) — Issuance Of Debt: 278250000.00
BH.A cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 12250000.00
BH.A balance_sheet (annual, 2025-12-31) — Land And Improvements: 289333000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 289333000.00
BH.A balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 97701000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 97701000.00
BH.A balance_sheet (annual, 2025-12-31) — Long Term Debt: 213920000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 213920000.00
BH.A balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 311621000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 311621000.00
BH.A cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 278250000.00
BH.A cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 55250000.00
BH.A cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -79850000.00
BH.A cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -75572000.00
BH.A balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 154275000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 154275000.00
BH.A balance_sheet (annual, 2025-12-31) — Long Term Provisions: 15542000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 15542000.00
BH.A balance_sheet (annual, 2025-12-31) — Minority Interest: 0.00
BH.A balance_sheet (quarterly, 2025-12-31) — Minority Interest: 0.00
BH.A income_statement (annual, 2025-12-31) — Minority Interests: 0.00
BH.A cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -89115000.00
BH.A cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -44150000.00
BH.A income_statement (annual, 2025-12-31) — Net Income: -37488000.00
BH.A income_statement (quarterly, 2025-12-31) — Net Income: -49853000.00
BH.A income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -37488000.00
BH.A income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -49853000.00
BH.A income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -37488000.00
BH.A income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -49853000.00
BH.A income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -37488000.00
BH.A income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -49853000.00
BH.A income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -37488000.00
BH.A income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -49853000.00
BH.A cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -37488000.00
BH.A cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -49853000.00
BH.A income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -37488000.00
BH.A income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -49853000.00
BH.A income_statement (annual, 2025-12-31) — Net Interest Income: -13642000.00
BH.A income_statement (quarterly, 2025-12-31) — Net Interest Income: -6980000.00
BH.A cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 33019000.00
BH.A cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 23272000.00
BH.A cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 198400000.00
BH.A cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 9678000.00
BH.A cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 198400000.00
BH.A cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -20322000.00
BH.A income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -13642000.00
BH.A income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -6980000.00
BH.A cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1867000.00
BH.A balance_sheet (annual, 2025-12-31) — Net PPE: 406659000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Net PPE: 406659000.00
BH.A cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 20979000.00
BH.A cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 3011000.00
BH.A balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 447187000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 447187000.00
BH.A balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 18029000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 18029000.00
BH.A balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 18029000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 18029000.00
BH.A income_statement (annual, 2025-12-31) — Normalized EBITDA: -4424000.00
BH.A income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -45735000.00
BH.A income_statement (annual, 2025-12-31) — Normalized Income: -46255044.00
BH.A income_statement (quarterly, 2025-12-31) — Normalized Income: -49356477.88
BH.A cash_flow (annual, 2025-12-31) — Operating Cash Flow: 106959000.00
BH.A cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 17771000.00
BH.A cash_flow (annual, 2025-12-31) — Operating Gains Losses: 50858000.00
BH.A cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 60754000.00
BH.A income_statement (annual, 2025-12-31) — Operating Income: 21798000.00
BH.A income_statement (quarterly, 2025-12-31) — Operating Income: 3576000.00
BH.A income_statement (annual, 2025-12-31) — Operating Revenue: 395261000.00
BH.A income_statement (quarterly, 2025-12-31) — Operating Revenue: 99869000.00
BH.A balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 3102960.00
BH.A balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 3102960.00
BH.A balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 33070000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 33070000.00
BH.A balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 18220000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 18220000.00
BH.A balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -1350000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -1350000.00
BH.A income_statement (annual, 2025-12-31) — Other Income Expense: -55847000.00
BH.A income_statement (quarterly, 2025-12-31) — Other Income Expense: -60654000.00
BH.A balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 23674000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 23674000.00
BH.A balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 9681000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 9681000.00
BH.A balance_sheet (annual, 2025-12-31) — Other Payable: 5596000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Other Payable: 5596000.00
BH.A balance_sheet (annual, 2025-12-31) — Other Properties: 253447000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Other Properties: 253447000.00
BH.A balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 69050000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 69050000.00
BH.A balance_sheet (annual, 2025-12-31) — Payables: 49853000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Payables: 49853000.00
BH.A balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 57589000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 57589000.00
BH.A balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5975000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5975000.00
BH.A balance_sheet (annual, 2025-12-31) — Prepaid Assets: 8634000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 8634000.00
BH.A income_statement (annual, 2025-12-31) — Pretax Income: -47691000.00
BH.A income_statement (quarterly, 2025-12-31) — Pretax Income: -64058000.00
BH.A balance_sheet (annual, 2025-12-31) — Properties: 157960000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Properties: 157960000.00
BH.A cash_flow (annual, 2025-12-31) — Purchase Of Business: -89115000.00
BH.A cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -44150000.00
BH.A cash_flow (annual, 2025-12-31) — Purchase Of Investment: -57843000.00
BH.A cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -9468000.00
BH.A balance_sheet (annual, 2025-12-31) — Receivables: 23283000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Receivables: 23283000.00
BH.A income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 245846000.00
BH.A income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 63393000.00
BH.A income_statement (annual, 2025-12-31) — Reconciled Depreciation: 40779000.00
BH.A income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 10705000.00
BH.A cash_flow (annual, 2025-12-31) — Repayment Of Debt: -79850000.00
BH.A cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -2572000.00
BH.A balance_sheet (annual, 2025-12-31) — Retained Earnings: 590211000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 590211000.00
BH.A cash_flow (annual, 2025-12-31) — Sale Of Investment: 90862000.00
BH.A cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 32740000.00
BH.A cash_flow (annual, 2025-12-31) — Sale Of PPE: 20979000.00
BH.A cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 3011000.00
BH.A income_statement (annual, 2025-12-31) — Selling General And Administration: 86838000.00
BH.A income_statement (quarterly, 2025-12-31) — Selling General And Administration: 22195000.00
BH.A balance_sheet (annual, 2025-12-31) — Share Issued: 3102960.00
BH.A balance_sheet (quarterly, 2025-12-31) — Share Issued: 3102960.00
BH.A income_statement (annual, 2025-12-31) — Special Income Charges: 10626000.00
BH.A income_statement (quarterly, 2025-12-31) — Special Income Charges: 1665000.00
BH.A balance_sheet (annual, 2025-12-31) — Stockholders Equity: 523429000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 523429000.00
BH.A balance_sheet (annual, 2025-12-31) — Tangible Book Value: 447187000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 447187000.00
BH.A income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 2386956.00
BH.A income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -141477.88
BH.A income_statement (annual, 2025-12-31) — Tax Provision: -10203000.00
BH.A income_statement (quarterly, 2025-12-31) — Tax Provision: -14205000.00
BH.A income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
BH.A income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.22
BH.A balance_sheet (annual, 2025-12-31) — Total Assets: 1025383000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Total Assets: 1025383000.00
BH.A balance_sheet (annual, 2025-12-31) — Total Capitalization: 737349000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 737349000.00
BH.A balance_sheet (annual, 2025-12-31) — Total Debt: 358637000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Total Debt: 358637000.00
BH.A balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 523429000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 523429000.00
BH.A income_statement (annual, 2025-12-31) — Total Expenses: 373463000.00
BH.A income_statement (quarterly, 2025-12-31) — Total Expenses: 96293000.00
BH.A balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 501954000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 501954000.00
BH.A balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 646857000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 646857000.00
BH.A balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 345959000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 345959000.00
BH.A balance_sheet (annual, 2025-12-31) — Total Tax Payable: 10084000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 10084000.00
BH.A income_statement (annual, 2025-12-31) — Total Unusual Items: 11154000.00
BH.A income_statement (quarterly, 2025-12-31) — Total Unusual Items: -638000.00
BH.A income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 11154000.00
BH.A income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -638000.00
BH.A balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 767000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 767000.00
BH.A balance_sheet (annual, 2025-12-31) — Treasury Stock: 452164000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 452164000.00
BH.A balance_sheet (annual, 2025-12-31) — Working Capital: 222531000.00
BH.A balance_sheet (quarterly, 2025-12-31) — Working Capital: 222531000.00
BH.A income_statement (quarterly, 2026-03-31) — +Operating Expense: 35529000.00
BH.A income_statement (quarterly, 2026-03-31) — +Total Revenue: 97481000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 32030000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 24942000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -474928000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 400505000.00
BH.A cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 274000.00
BH.A income_statement (quarterly, 2026-03-31) — Basic Average Shares: 260386.00
BH.A income_statement (quarterly, 2026-03-31) — Basic EPS: -55.80
BH.A cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 269493000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 173940000.00
BH.A cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -6967000.00
BH.A cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -6967000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 117774000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1147000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 200075000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 314262000.00
BH.A cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 6057000.00
BH.A cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -95143000.00
BH.A cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 20332000.00
BH.A cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -5047000.00
BH.A cash_flow (quarterly, 2026-03-31) — Change In Receivables: -2477000.00
BH.A cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -7524000.00
BH.A cash_flow (quarterly, 2026-03-31) — Changes In Cash: -68754000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Common Stock: 1147000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 519160000.00
BH.A cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 14920000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 2064000.00
BH.A income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 59085000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 6610000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Current Assets: 356210000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 12609000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Current Debt: 28262000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 40871000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 29354000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 29354000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 144318000.00
BH.A cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 3501000.00
BH.A cash_flow (quarterly, 2026-03-31) — Deferred Tax: 3501000.00
BH.A cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 10657000.00
BH.A income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 10657000.00
BH.A cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 10657000.00
BH.A income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 260386.00
BH.A income_statement (quarterly, 2026-03-31) — Diluted EPS: -55.80
BH.A income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -14531000.00
BH.A cash_flow (quarterly, 2026-03-31) — Dividend Received Cfo: 13020000.00
BH.A income_statement (quarterly, 2026-03-31) — EBIT: -11874000.00
BH.A income_statement (quarterly, 2026-03-31) — EBITDA: -1217000.00
BH.A income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: -13454000.00
BH.A cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 47000.00
BH.A cash_flow (quarterly, 2026-03-31) — End Cash Position: 200786000.00
BH.A cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 6057000.00
BH.A cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 13365000.00
BH.A cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 14741000.00
BH.A income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 0.00
BH.A income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -1287000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -1570000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Goodwill: 52555000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 76080000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Gross PPE: 885164000.00
BH.A income_statement (quarterly, 2026-03-31) — Gross Profit: 38396000.00
BH.A income_statement (quarterly, 2026-03-31) — Interest Expense: 7008000.00
BH.A income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 7008000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Inventory: 3520000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Invested Capital: 759098000.00
BH.A cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -95143000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 165493000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 165493000.00
BH.A cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 14920000.00
BH.A cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 1250000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 293848000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 105165000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 211676000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 316841000.00
BH.A cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 1250000.00
BH.A cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -10059000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 165493000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 15700000.00
BH.A cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -42130000.00
BH.A cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 14920000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Net Debt: 39863000.00
BH.A income_statement (quarterly, 2026-03-31) — Net Income: -14531000.00
BH.A income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -14531000.00
BH.A income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -14531000.00
BH.A income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -14531000.00
BH.A income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -14531000.00
BH.A cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -14531000.00
BH.A income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -14531000.00
BH.A income_statement (quarterly, 2026-03-31) — Net Interest Income: -7008000.00
BH.A cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -46184000.00
BH.A cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -8809000.00
BH.A cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -8809000.00
BH.A income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -7008000.00
BH.A cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -54000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Net PPE: 410236000.00
BH.A cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 138000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 443080000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 21509000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 21509000.00
BH.A income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 70000.00
BH.A income_statement (quarterly, 2026-03-31) — Normalized Income: -13540564.82
BH.A cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 20332000.00
BH.A cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 14935000.00
BH.A income_statement (quarterly, 2026-03-31) — Operating Income: 2867000.00
BH.A income_statement (quarterly, 2026-03-31) — Operating Revenue: 97481000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 3139020.00
BH.A balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 13486000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 28262000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 18755000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -1570000.00
BH.A income_statement (quarterly, 2026-03-31) — Other Income Expense: -14741000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 23525000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 10278000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 769000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Other Payable: 6395000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Other Properties: 256626000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 114187000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Payables: 43689000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 50299000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 5039000.00
BH.A income_statement (quarterly, 2026-03-31) — Pretax Income: -18882000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Properties: 158686000.00
BH.A cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -42130000.00
BH.A cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -53414000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Receivables: 24942000.00
BH.A income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 59085000.00
BH.A income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 10657000.00
BH.A cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -10059000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 575680000.00
BH.A cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 7230000.00
BH.A cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 138000.00
BH.A income_statement (quarterly, 2026-03-31) — Selling General And Administration: 24872000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Share Issued: 3139020.00
BH.A income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
BH.A balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 519160000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 443080000.00
BH.A income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -296564.82
BH.A income_statement (quarterly, 2026-03-31) — Tax Provision: -4351000.00
BH.A income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.23
BH.A balance_sheet (quarterly, 2026-03-31) — Total Assets: 1018297000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 730836000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Total Debt: 357712000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 519160000.00
BH.A income_statement (quarterly, 2026-03-31) — Total Expenses: 94614000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 499137000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 662087000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 354819000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 5264000.00
BH.A income_statement (quarterly, 2026-03-31) — Total Unusual Items: -1287000.00
BH.A income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -1287000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 456602000.00
BH.A balance_sheet (quarterly, 2026-03-31) — Working Capital: 211892000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -682226000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 552476000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -1160000.00
BHAGCHEM.NS income_statement (annual, 2022-03-31) — Amortization: 1268000.00
BHAGCHEM.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 1268000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 211986000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 0.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 22033000.00
BHAGCHEM.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -8310000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 7462000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 4576000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 165000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 179695000.00
BHAGCHEM.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 43735000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 967046000.00
BHAGCHEM.NS income_statement (annual, 2022-03-31) — Interest Income: 2663000.00
BHAGCHEM.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 2663000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Investmentsin Subsidiariesat Cost: 0.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 119314000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 0.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 375000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 1742938000.00
BHAGCHEM.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 0.00
BHAGCHEM.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: 1000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 12198000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 38784000.00
BHAGCHEM.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 3651000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 1000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Other Payable: 63394000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 1031000.00
BHAGCHEM.NS cash_flow (annual, 2022-03-31) — Pension And Employee Benefit Expense: 5615000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 56960000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
BHAGCHEM.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: 1160000.00
BHAGCHEM.NS cash_flow (annual, 2022-03-31) — Purchase Of Business: 0.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 391586000.00
BHAGCHEM.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 3470000.00
BHAGCHEM.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 3470000.00
BHAGCHEM.NS income_statement (annual, 2022-03-31) — Research And Development: 14374000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 8321000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 1169802000.00
BHAGCHEM.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 50744000.00
BHAGCHEM.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 94479000.00
BHAGCHEM.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 38924000.00
BHAGCHEM.NS balance_sheet (annual, 2022-03-31) — Work In Process: 104401000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — +Operating Expense: 530136000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — +Total Revenue: 5019990000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 588194000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1287652000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -776944000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 1356242000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Amortization: 1062000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 1062000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 7102000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 101815500.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Basic EPS: 4.43
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 22034000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 227562000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -598260000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 2252000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 104055000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 29354000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 29415000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -31216000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 0.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 29354000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -233842000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 15619000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -3073000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Change In Payable: 40556000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -321766000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -502506000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 7462000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Common Stock: 104055000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -31216000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 3132498000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 824478000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 382899000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 3813153000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Current Assets: 2282535000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 135000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Current Debt: 333998000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 334133000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 0.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 1007525000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Depreciation: 97017000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 98079000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 98079000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 97017000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 101815500.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Diluted EPS: 4.43
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 451516000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 85000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — EBIT: 662125000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — EBITDA: 760204000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: -142000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — End Cash Position: 29355000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 464655000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 353495000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -459319000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 47000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 55203000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 4943000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 1287652000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 2893205000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Gross Profit: 1206837000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Interest Expense: 24294000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 24294000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Interest Income: 3465000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 3465000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -22874000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 3465000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Inventory: 913174000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 3632215000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -596134000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 7102000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Investmentsin Subsidiariesat Cost: 0.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 824478000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 125057000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 2117000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 165719000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 167836000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 0.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 1968895000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 824478000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Net Debt: 470363000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -2555000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Net Income: 451516000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 451516000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 451516000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 451516000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 451516000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 637831000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 451516000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Net Interest Income: -46467000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -2390000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -305732000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 65418000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -46467000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -1000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -1000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Net PPE: 2116261000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -597208000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -371150000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 3127555000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 10673000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 150610000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 0.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 45521000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 760204000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Normalized Income: 451516000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 138941000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Operating Income: 676701000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Operating Revenue: 5019990000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 104054830.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 1000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: -1000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 3028442000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 4943000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 3239000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 19306000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -1000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: -1000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 1795000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 10441000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Payable: 78126000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Properties: 188792000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 1343000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 61000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Payables: 666405000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 8183000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 6988000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 40400000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Pretax Income: 637831000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 0.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: 0.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -598260000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 385984000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 3813153000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 98079000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 3750000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 3750000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Research And Development: 15984000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 9356000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 1581927000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 1052000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 53432000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 108635000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Share Issued: 104054830.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Special Income Charges: 0.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 3132498000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 3127555000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Tax Provision: 186315000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.29
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 1194000.00
BHAGCHEM.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -119443000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Assets: 4469141000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 3298217000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Debt: 501969000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 3132498000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Total Expenses: 4343289000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 1336643000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 2186605000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 329118000.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 25638000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 0.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 0.00
BHAGCHEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Work In Process: 170456000.00
BHAGCHEM.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1275010000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — +Operating Expense: 594945000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — +Total Revenue: 4074986000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 652530000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1071026000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -864488000.00